Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetics-Guided Pharmacotherapy for Smoking Cessation
NCT03362099Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2016
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, bupropion in nicotine dependence, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Nov 2016; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03362099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362099.